Cambridge Healthtech Institute’s 3rd Annual

Cell Culture to Bioproduction

Accelerating Productivity

24-25 March 2020


Cambridge Healthtech Institute’s Cell Culture to Bioproduction conference examines the strategies that lead to greater productivity when cultivating cells and scaling up production. Emerging research and technologies are breathing new life into bioproduction, especially with genomic research and CRISPR engineering. Also, predictive technologies, such as PAT and DoE, have changed the way scientists develop methods and assess risks. In all, the conference explores how to increase productivity, while minimizing time and cost in order to provide the materials needed to create tomorrow's biopharmaceuticals.

Preliminary Agenda


KEYNOTE PRESENTATION: There’s Still a Place for People in Technology & AI

David Stewart, MSc, Senior Director, Site Quality Lead, Next Generation Manufacturing, Biogen

Machine Learning for Effective Bioprocess Development

Moritz von Stosch, PhD, Head, Process Systems Biology and Engineering Center of Excellence of Technical R&D, GSK Biologicals


Process Intensification Strategies Based on Single-Use Equipment

Stefan R. Schmidt, PhD, MBA, COO, Head, Operations, BioAtrium AG

Know Your Bioreactors: From Computational Fluid Dynamics to a Digital Process Twin

Krist Gernaey, PhD, Professor, Head, Process and Systems Engineering Center (PROSYS), Chemical and Biochemical Engineering, Technical University of Denmark


Making Cell Culture More Physiological: Considering the Secretome and Extracellular Matrix

Josephine Adams, PhD, Professor, Cell Biology, University of Bristol

Towards Improved Efficiency by Cell Line Engineering and Process Optimization 

Lisa Alexandra Pieper, PhD, Associate Director, Cell Culture, Bioprocess and Analytical Development, Boehringer Ingelheim Pharma GmbH & Co. KG


High-Resolution Optical and Dielectric Methods for Monitoring Cells in Bioprocesses

Michael Butler, PhD, CSO, Cell Technology, National Institute for Bioprocessing Research and Training (NIBRT)

New Generation of Intelligent Sensors to Minimize Bioprocess VariabilityHamilton-Excellence

Giovanni Campolongo Market Segment Manager Process Analytics Process Analytics Hamilton Bonaduz AG

Process Intensification and Real-Time Monitoring Technologies to Accelerate Upstream Bioprocess Development

Johannes Wirth, MSc, Scientist, Bio Process Science, Rentschler Biopharma SE

Quality by Control Implementation to Bioprocesses Using an Advanced Software PlatformBilfinger

Wolfgang Sommeregger PhD Research & Development Bilfinger Industrietechnik Salzburg GmbH

Toward Biotherapeutic Product Real-Time Quality Monitoring

Jarka Glassey, PhD, Professor, Chemical Engineering, Engineering, Newcastle University


Advanced Control Strategies in Upstream Processing

Gerald Striedner, PhD, Associate Professor, Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU)

Hybrid Modeling and Intensified DOE Enabling Faster Process Understanding and Model Predictive Control

Mark Dürkop, PhD, Project Leader, Biotechnology, University of Natural Resources and Life Sciences, Vienna (BOKU); Co-Founder and CEO of Novasign

Data Science or PAT as Control Strategies for Continuous Biomanufacturing

Christoph Herwig, PhD, Professor and Head, Biochemical Engineering, Chemical Environmental and Bioscience Engineering, Technical University of Vienna (TU Wien)

Enabling PAT in Insect Cell Processes for rAAV Production

Inês Isidro, PhD, Scientist, Computational Biotechnology, Animal Cell Technology, iBET Instituto de Biologia Experimental Tecnologica

For more details on the conference, please contact:
Mary Ruberry

Senior Conference Director

Cambridge Healthtech Institute

Phone: 1-781-972-5421



For partnering and sponsorship information, please contact:

Companies A-K

Sherry Johnson

Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-1359



Companies L-Z

Carolyn Cooke

Business Development Manager

Cambridge Healthtech Institute

Phone: 781-972-5412